The Impact of Implementing
3D Printing at the Point-of-Care
by Todd Pietila Global Business Development Manager for Hospital 3D Printing, Materialise
Date published: October 2018
3D printing at the point of care has taken off since the first patient-specific anatomical models were created from medical imaging data as early as 1981. Given the momentum of the industry and mounting patient-care evidence, the outlook for 3D printing is positive and growth is expected to continue.
What you’ll learn in this whitepaper:
- Proof points on why 3D printing is changing the way doctors plan surgeries, including for complex congenital heart disease and urological cases
- Economic benefits of 3D printing at the point-of-care through cost-saving and avoidance
- The value of 3D prints in learning and outreach, such as for clinical training sessions, explaining cases to patients and for marketing and public relations.
- How 3D printing spurs innovation at hospitals, opening the possibility for obtaining research grants, prototyping new ideas
About Materialise Medical
Materialise is a global 3D printing software and services company whose medical division is dedicated to enabling researchers, engineers, and clinicians to revolutionize patient-specific treatment that improves and saves lives. Our open and flexible platform, Materialise Mimics, forms the foundation of certified Medical 3D Printing and incorporates a comprehensive range of software solutions and 3D printing services. With over 27 years of excellence, we work alongside our customers in healthcare, automotive, aerospace, consumer goods, art, and design, to build groundbreaking 3D printing applications that make the world a better and healthier place.